Skip to main content

Table 5 Raw data of all patients of the study

From: Retrospective study of Dana Farber Consortium Protocol in newly diagnosed Egyptian adolescents and young adults with acute lymphoblastic leukemia: Tanta experience

No

Age ( years)

Sex

Total leucocytic count x109/L

Hemoglobin (g/dl)

Platelets ×109/L

Bone marrow blast (%)

Immunophenotyping

Philadelphia chromosome

Cytogenetics

Response

Relapsed

FATE

1

31

M

4

9

35

65

B

Negative

Normal

Refractory

N/A

Dead

2

23

M

13

13

223

66

B

Negative

Abnormal

Refractory

N/A

Dead

3

20

F

129

8.3

50

47

T

Negative

Abnormal

CR

No

Alive

4

31

M

77

10

55

96

B

Negative

Normal

CR

No

Alive

5

24

M

3

8.6

25

80

B

Negative

Normal

CR

No

Alive

6

32

M

14

12

18

72

B

Negative

Abnormal

CR

Yes

Dead

7

32

M

75

13

8

82

B

Positive

Abnormal

CR

Yes

Dead

8

21

M

97

7.6

53

70

B

Positive

Abnormal

CR

No

Alive

9

29

F

24

7.7

31

95

B

Negative

Normal

CR

No

Alive

10

26

M

7

13.6

206

42

T

Negative

Normal

CR

No

Alive

11

39

M

138

12.5

180

57

B

Negative

Normal

CR

Yes

Alive

12

27

F

4

9.2

27

95

T

Negative

Normal

CR

No

Alive

13

33

M

3

9

190

42

T

Negative

Normal

CR

Yes

Dead

14

18

M

10

11

98

25

T

Negative

Normal

CR

No

Alive

15

20

M

9

14

224

27

T

Negative

Normal

CR

No

Alive

16

28

F

4

9

160

80

T

Negative

Normal

CR

Yes

Alive

17

21

M

9

9

89

80

B

Positive

Abnormal

CR

No

Alive

18

26

M

3

5

80

91

B

Positive

Abnormal

CR

No

Alive

19

20

M

7

9.5

33

95

B

Negative

Normal

CR

No

Alive

20

27

M

41

8.7

50

94

B

Negative

Abnormal

CR

No

Alive

21

33

M

1

10

141

80

T

Negative

Normal

CR

Yes

Dead

22

22

M

6

7

196

83

T

Negative

Normal

CR

Yes

Alive

23

31

M

5

8

80

67

B

Negative

Normal

CR

Yes

Dead

24

23

M

17

8

53

90

T

Negative

Normal

CR

No

Alive

25

22

M

126

6.3

65

90

T

Negative

Normal

CR

No

Alive

26

35

M

5

6

60

85

B

Positive

Abnormal

CR

No

Alive

27

35

M

137

8.4

46

80

B

Negative

Normal

CR

No

Alive

28

34

F

88.2

8.3

57

90

B

Negative

Normal

CR

No

Alive

29

32

M

10.3

5.4

104

67

B

Negative

Normal

CR

No

Alive

30

30

F

90

7.2

60

87

B

Positive

Abnormal

CR

Yes

Dead

31

39

F

1

8.3

54

23

B

Negative

Abnormal

Refractory

N/A

Dead

32

33

F

43

9.6

13

73

B

Negative

Normal

CR

No

Alive

33

39

M

16

13.6

253

22

B

Negative

Normal

CR

Yes

Alive

34

23

M

138

8.7

46

90

B

Negative

Normal

CR

No

Alive

35

19

M

1.7

9.1

17

41

B

Negative

Normal

CR

No

Alive

36

30

F

52.9

8.5

40

90

B

Negative

Abnormal

CR

No

Alive

37

25

F

11.3

10.7

83

57

B

Negative

Normal

CR

No

Alive

38

31

F

38

8.9

55

37

B

Positive

Abnormal

CR

Yes

Dead

39

33

F

44

7.4

94

34

B

Positive

Abnormal

CR

No

Alive

40

27

F

63

10

121

61

B

Negative

Normal

CR

No

Alive

41

19

M

19

9.3

112

49

B

Negative

Normal

CR

No

Alive

  1. CR complete remission, F female, M male, N/A not applicable